Navigation Links
goBalto Raises Series A Financing to Advance Cloud-based Health Technologies
Date:10/19/2011

SAN FRANCISCO, October 19, 2011 /PRNewswire/ --

goBalto, developer of new generation web-based clinical research solutions, announced today that it has raised an undisclosed amount in Series A financing from Silicon Valley-based health technology investors Aberdare Ventures and the West Health Investment Fund.  The funds will be used to expand goBalto's corporate activities and to enhance Tracker™, its Software-as-a-Service (SaaS) clinical trials platform that was launched in June 2011.

"This funding is testimony to goBalto's roadmap for providing cost-effective, easy-to-use clinical trials solutions to the pharmaceutical, biotechnology and medical device industries," said Jae Chung, founder and CEO of goBalto.  "Since its creation, goBalto has been led and supported by leading health and software engineering veterans. Our new partners will strengthen our team's mission to support customers as they embrace the use of the cloud to adjust to regulatory changes and costs associated with bringing new products through to market."

"Jae has purposefully built a team merging top technical talent with deep clinical research knowledge to develop Tracker," added Darren Hite, principal at Aberdare Ventures. "goBalto's software products streamline workflow, reduce clinical trial startup time and costs, but perhaps most importantly, are intuitive and enjoyable for all stakeholders to use."

"This investment reflects Silicon Valley's growing interest in creative startups that are applying cloud technology to health, with the potential to significantly lower health care costs," said Don Casey, manager of the West Health Investment Fund.

Mohit Kaushal, co-manager of the West Health Investment Fund, added, "We're very excited to work with goBalto to help reduce barriers for companies to conduct clinical trials. Decreasing the cost of innovation within health care is a core focus for the West Health Investment Fund."

As part of the financing, goBalto will create a board of directors including Jae Chung and Darren Hite. Mohit Kaushal will serve as an independent board observer.

Previously, the company had been financed by investments from Jae Chung and angel investors.

About goBalto

goBalto is a developer of new generation web-based solutions that simplify how clinical trials are conducted in the pharmaceutical, biotechnology and medical device industries.  Tracker™, launched in June 2011, is the first purpose-built Software-as-a-Service clinical research tool that enables clinical trials sponsors to collaborate with multiple partners directly from the web in a transparent and regulatory compliant manner.  Founded in Silicon Valley in 2008 by biotechnology industry veteran Jae Chung and backed by leading health technology investors, goBalto applies Agile and lean startup methodologies to building technological solutions that address evolving global healthcare.  Visit http://www.gobalto.com for more information.

About Aberdare Ventures

Aberdare Ventures is a venture firm that focuses on a limited number of entrepreneurial teams committed to building leading healthcare technology companies. They limit their commitments in the belief that their involvement can increase the probability of success for their portfolio companies and generate greater returns for their investors.  Visit http://www.aberdare.com for more information.

About The West Health Investment Fund

The West Health Investment Fund (http://www.westhealthfund.com) is the first investment fund with the mission to lower health care costs for the public by providing risk capital for health care technologies and services. Launched by entrepreneurs and philanthropists Gary and Mary West, the Fund aims to spur a whole new ecosystem for low cost health care innovation.


'/>"/>
SOURCE goBalto
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Grateful Weight Loss Patient Praises Micro Gastric Sleeve Surgery
2. CoLucid Pharmaceuticals Raises $7.5 Million of Planned $9.5 Million
3. LUNGevity Foundation Praises Recent FDA Approval of New Lung Cancer Treatment Drug XALKORI® (crizotinib)
4. Enobia Pharma Raises US $40 Million
5. NxStage Reports Record Second Quarter 2011 Financial Results and Raises Revenue Guidance for 2011
6. Successful First Half of 2011: Sartorius Raises Full-year Guidance
7. Vantia Therapeutics Raises £4 Million to Fund Clinical Development of its Lead Compounds
8. Reportlinker Adds Product Profiles: Multiple Sclerosis - Gilenya Raises Bar for New Market Entrants
9. Maroon 5 Lead Singer Adam Levine Raises Awareness of Attention-Deficit/Hyperactivity Disorder in Young Adults and Adults With "Own It"
10. ULURU Inc. Raises $140,000 in Convertible Debt Offering
11. Cardinal Health Raises Quarterly Dividend By 10 Percent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... , July 11, 2017 Oramed Pharmaceuticals ... a clinical-stage pharmaceutical company focused on the development of ... Food and Drug Administration (FDA) has agreed to schedule ... completed Phase IIb trial of its oral insulin capsule ... Phase IIb trial met primary and secondary endpoints by ...
(Date:7/10/2017)... CARLSBAD, Calif. , July 10, 2017  The ... in Boston, MA at the ... unequaled value and unparalleled access to global decision makers ... to draw 800+ life science leaders during two impactful ... Boston, and provides delegates with additional networking opportunities with ...
(Date:7/5/2017)... JERUSALEM , July 5, 2017 ... www.oramed.com ), a clinical-stage pharmaceutical company ... today that it has received approval from the Israel Securities ... Stock Exchange (TASE). Oramed common stock will commence trading on ... Based on the current market capitalization of the Company, it ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... 2017 , ... The Bryant Agency, a Georgia based firm ... in the Dalton region, is working in conjunction with the GreenHouse organization in ... abuse. , The GreenHouse is headquartered in Dalton and provides a refuge for ...
(Date:7/21/2017)... , ... July 21, 2017 , ... ... assistance and financial planning services to communities in the greater Birmingham area, is ... provide resources to underprivileged young people in the region. , The Chris Hammond ...
(Date:7/21/2017)... ... , ... Hospital M&A activity slowed in the second quarter of 2017, according ... to 23 in the second quarter, up 15% from the 20 publicly announced acquisitions ... in the year-ago second quarter. Only four of the transactions disclosed a purchase price ...
(Date:7/21/2017)... ... July 21, 2017 , ... The ... grant from the C. R. Bard Foundation, Inc. to support the ... , a service available through the nonprofit home care agency. Using evidence-based methods, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased to announce the ... July 17, 2017, Ms. Vu will join West Dermatology’s large network of medical and ... skin cancer , and more. She graduated from the University of Florida College ...
Breaking Medicine News(10 mins):